INmune Bio, Inc. (INMB)

USD 7.76

(2.24%)

Revenue Summary of INmune Bio, Inc.

  • INmune Bio, Inc.'s latest annual revenue in 2023 was 155 Thousand USD , down -58.56% from previous year.
  • INmune Bio, Inc.'s latest quarterly revenue in 2024 Q3 was - USD , down 0.0% from previous quarter.
  • INmune Bio, Inc. reported a annual revenue of 374 Thousand USD in annual revenue 2022, up 106.63% from previous year.
  • INmune Bio, Inc. reported a annual revenue of 181 Thousand USD in annual revenue 2021, up 1558.12% from previous year.
  • INmune Bio, Inc. reported a quarterly revenue of - USD for 2024 Q3, down 0.0% from previous quarter.
  • INmune Bio, Inc. reported a quarterly revenue of 14 Thousand USD for 2024 Q1, down -50.0% from previous quarter.

Annual Revenue Chart of INmune Bio, Inc. (2023 - 2015)

Historical Annual Revenue of INmune Bio, Inc. (2023 - 2015)

Year Revenue Revenue Growth
2023 155 Thousand USD -58.56%
2022 374 Thousand USD 106.63%
2021 181 Thousand USD 1558.12%
2020 10.91 Thousand USD -99.99%
2019 77.68 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%

Peer Revenue Comparison of INmune Bio, Inc.

Name Revenue Revenue Difference
Absci Corporation 5.71 Million USD 97.289%
Adaptive Biotechnologies Corporation 170.27 Million USD 99.909%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.992%
Alzamend Neuro, Inc. - USD -Infinity%
Apollomics, Inc. 821 Thousand USD 81.121%
180 Life Sciences Corp. - USD -Infinity%
Atossa Therapeutics, Inc. - USD -Infinity%
Bicycle Therapeutics plc 26.97 Million USD 99.425%
Barinthus Biotherapeutics plc 802 Thousand USD 80.673%
BioXcel Therapeutics, Inc. 1.38 Million USD 88.768%
CASI Pharmaceuticals, Inc. 33.87 Million USD 99.542%
Chimerix, Inc. 324 Thousand USD 52.16%
CRISPR Therapeutics AG 371.2 Million USD 99.958%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 99.69%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 99.663%
Fortress Biotech, Inc. 84.51 Million USD 99.817%
Fortress Biotech, Inc. 84.51 Million USD 99.817%
Gritstone bio, Inc. 1.33 Million USD 88.355%
Allakos Inc. - USD -Infinity%
Boundless Bio, Inc. Common Stock - USD -Infinity%
Cara Therapeutics, Inc. 20.96 Million USD 99.261%
Cytokinetics, Incorporated 7.53 Million USD 97.942%
enGene Holdings Inc. Common Stock - USD -Infinity%
Innoviva, Inc. 310.46 Million USD 99.95%
Hoth Therapeutics, Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
Terns Pharmaceuticals, Inc. - USD -Infinity%
Vigil Neuroscience, Inc. - USD -Infinity%
ImmuCell Corporation 17.47 Million USD 99.113%
IDEAYA Biosciences, Inc. 23.38 Million USD 99.337%
Incyte Corporation 3.69 Billion USD 99.996%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD 81.37%
Lexaria Bioscience Corp. 226.2 Thousand USD 31.479%
Mustang Bio, Inc. - USD -Infinity%
MiMedx Group, Inc. 321.47 Million USD 99.952%
MEI Pharma, Inc. 65.29 Million USD 99.763%
MacroGenics, Inc. 58.74 Million USD 99.736%
Monopar Therapeutics Inc. - USD -Infinity%
Mereo BioPharma Group plc 10 Million USD 98.45%
Marker Therapeutics, Inc. 3.31 Million USD 95.319%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 99.5%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.946%
Minerva Neurosciences, Inc. - USD -Infinity%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
NeuroSense Therapeutics Ltd. - USD -Infinity%
NextCure, Inc. - USD -Infinity%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 94.384%
Ocuphire Pharma, Inc. 19.04 Million USD 99.186%
Onconetix, Inc. 58.46 Thousand USD -165.116%
Oncternal Therapeutics, Inc. 785 Thousand USD 80.255%
Opthea Limited 261.85 Thousand USD 40.808%
Ovid Therapeutics Inc. 391.69 Thousand USD 60.428%
Psyence Biomedical Ltd. - USD -Infinity%
PDS Biotechnology Corporation - USD -Infinity%
Precigen, Inc. 6.22 Million USD 97.51%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 99.638%
Prime Medicine, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 95.345%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 99.999%
Replimune Group, Inc. - USD -Infinity%
Revelation Biosciences, Inc. - USD -Infinity%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 99.867%
TransCode Therapeutics, Inc. - USD -Infinity%
Revolution Medicines, Inc. Warrant 11.58 Million USD 98.661%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 99.613%
Sangamo Therapeutics, Inc. 176.23 Million USD 99.912%
Solid Biosciences Inc. - USD -Infinity%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
SciSparc Ltd. 2.87 Million USD 94.616%
Sutro Biopharma, Inc. 153.73 Million USD 99.899%
TG Therapeutics, Inc. 233.66 Million USD 99.934%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 98.005%
Titan Pharmaceuticals, Inc. 184 Thousand USD 15.761%
Travere Therapeutics, Inc. 145.23 Million USD 99.893%
UroGen Pharma Ltd. 82.71 Million USD 99.813%
Verrica Pharmaceuticals Inc. 5.12 Million USD 96.975%
XOMA Corporation 4.75 Million USD 96.742%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
AbCellera Biologics Inc. 38.02 Million USD 99.592%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
Cassava Sciences, Inc. - USD -Infinity%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Precision BioSciences, Inc. 48.72 Million USD 99.682%
Dyadic International, Inc. 2.89 Million USD 94.653%
Intensity Therapeutics, Inc. - USD -Infinity%
Eton Pharmaceuticals, Inc. 31.64 Million USD 99.51%
VYNE Therapeutics Inc. 424 Thousand USD 63.443%
Tenaya Therapeutics, Inc. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 92.723%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Acelyrin, Inc. - USD -Infinity%
Abeona Therapeutics Inc. 3.5 Million USD 95.571%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 99.882%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD 40.499%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 99.902%
Syros Pharmaceuticals, Inc. 9.93 Million USD 98.44%
Senti Biosciences, Inc. 2.56 Million USD 93.948%
Mesoblast Limited 5.9 Million USD 97.374%
Kymera Therapeutics, Inc. 78.59 Million USD 99.803%
ChromaDex Corporation 83.57 Million USD 99.815%
BriaCell Therapeutics Corp. - USD -Infinity%
Akebia Therapeutics, Inc. 194.62 Million USD 99.92%
Dermata Therapeutics, Inc. - USD -Infinity%
Seer, Inc. 15.18 Million USD 98.979%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.905%
Novavax, Inc. 983.7 Million USD 99.984%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Fate Therapeutics, Inc. 63.53 Million USD 99.756%
Checkpoint Therapeutics, Inc. 103 Thousand USD -50.485%
Lyell Immunopharma, Inc. 130 Thousand USD -19.231%
Celcuity Inc. - USD -Infinity%
ContextLogic Inc. 287 Million USD 99.946%
Phathom Pharmaceuticals, Inc. 682 Thousand USD 77.273%
HOOKIPA Pharma Inc. 20.12 Million USD 99.23%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.996%
Amarin Corporation plc 306.91 Million USD 99.949%
AnaptysBio, Inc. 17.15 Million USD 99.097%
Aptevo Therapeutics Inc. - USD -Infinity%
Aptorum Group Limited 431.37 Thousand USD 64.069%
Cartesian Therapeutics, Inc. 26 Million USD 99.404%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.936%
Ardelyx, Inc. 124.45 Million USD 99.875%
Celularity Inc. 22.77 Million USD 99.319%
Omeros Corporation - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Immunocore Holdings plc 249.42 Million USD 99.938%
IO Biotech, Inc. - USD -Infinity%
GT Biopharma, Inc. - USD -Infinity%
Cabaletta Bio, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Alaunos Therapeutics, Inc. 5000.00 USD -3000.0%
Pulmatrix, Inc. 7.29 Million USD 97.876%
Intellia Therapeutics, Inc. 36.27 Million USD 99.573%
Evogene Ltd. 5.64 Million USD 97.252%
CorMedix Inc. - USD -Infinity%
BioLineRx Ltd. 4.8 Million USD 96.771%
VistaGen Therapeutics, Inc. 1.06 Million USD 85.432%
Sagimet Biosciences Inc. 2 Million USD 92.25%
PTC Therapeutics, Inc. 937.82 Million USD 99.983%
scPharmaceuticals Inc. 13.59 Million USD 98.86%
Fulcrum Therapeutics, Inc. 2.8 Million USD 94.474%
Corcept Therapeutics Incorporated 482.37 Million USD 99.968%
NLS Pharmaceutics AG - USD -Infinity%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Akero Therapeutics, Inc. - USD -Infinity%
Eliem Therapeutics, Inc. - USD -Infinity%
Lisata Therapeutics, Inc. - USD -Infinity%
Stoke Therapeutics, Inc. 8.78 Million USD 98.235%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Outlook Therapeutics, Inc. - USD -Infinity%
ProMIS Neurosciences, Inc. - USD -Infinity%
Daré Bioscience, Inc. 2.8 Million USD 94.48%
bluebird bio, Inc. 29.49 Million USD 99.475%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.994%
DBV Technologies S.A. 15.72 Million USD 99.014%
Avidity Biosciences, Inc. 9.56 Million USD 98.379%
Galecto, Inc. - USD -Infinity%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Spruce Biosciences, Inc. 10.08 Million USD 98.464%
Inhibrx Biosciences, Inc. 1.8 Million USD 91.389%
GlycoMimetics, Inc. 10 Thousand USD -1450.0%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 99.74%
ADMA Biologics, Inc. 258.21 Million USD 99.94%
Clene Inc. 654 Thousand USD 76.3%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 99.652%
Aptose Biosciences Inc. - USD -Infinity%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD 81.534%
Century Therapeutics, Inc. 2.23 Million USD 93.065%
Kura Oncology, Inc. - USD -Infinity%
Surrozen, Inc. - USD -Infinity%
TScan Therapeutics, Inc. 21.04 Million USD 99.264%
Ocean Biomedical, Inc. - USD -Infinity%
CytomX Therapeutics, Inc. 101.21 Million USD 99.847%
Autolus Therapeutics plc 1.69 Million USD 90.872%
Mineralys Therapeutics, Inc. - USD -Infinity%
Eterna Therapeutics Inc. 68 Thousand USD -127.941%
Caribou Biosciences, Inc. 34.47 Million USD 99.55%
GRI Bio, Inc. 21.76 Million USD 99.288%
Xenetic Biosciences, Inc. 2.53 Million USD 93.898%
Janux Therapeutics, Inc. 8.08 Million USD 98.082%
Heron Therapeutics, Inc. 127.04 Million USD 99.878%
SAB Biotherapeutics, Inc. 2.23 Million USD 93.077%
Pasithea Therapeutics Corp. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Jaguar Health, Inc. 9.76 Million USD 98.412%
Entero Therapeutics, Inc. - USD -Infinity%
Milestone Pharmaceuticals Inc. 1 Million USD 84.5%
Clearside Biomedical, Inc. 8.22 Million USD 98.116%
Atara Biotherapeutics, Inc. 8.57 Million USD 98.192%
Coherus BioSciences, Inc. 257.24 Million USD 99.94%
Verastem, Inc. - USD -Infinity%
Pliant Therapeutics, Inc. 1.58 Million USD 90.19%
Histogen Inc. 3.76 Million USD 95.888%
Aprea Therapeutics, Inc. 583.23 Thousand USD 73.424%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.979%
Surrozen, Inc. - USD -Infinity%
Organovo Holdings, Inc. 109 Thousand USD -42.202%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 97.738%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
BioRestorative Therapies, Inc. 145.8 Thousand USD -6.31%
Kronos Bio, Inc. 6.28 Million USD 97.535%
Turnstone Biologics Corp. 19.3 Million USD 99.197%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
Entrada Therapeutics, Inc. 129.01 Million USD 99.88%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 99.912%
Exelixis, Inc. 1.83 Billion USD 99.992%
Nurix Therapeutics, Inc. 76.98 Million USD 99.799%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.961%
Jasper Therapeutics, Inc. - USD -Infinity%
ESSA Pharma Inc. - USD -Infinity%
TNF Pharmaceuticals, Inc. - USD -Infinity%
Avid Bioservices, Inc. 139.91 Million USD 99.889%
Insmed Incorporated 305.2 Million USD 99.949%
MediWound Ltd. 18.68 Million USD 99.171%
OmniAb, Inc. 34.16 Million USD 99.546%
Alector, Inc. 97.06 Million USD 99.84%
Seres Therapeutics, Inc. 126.32 Million USD 99.877%
Zai Lab Limited 266.71 Million USD 99.942%
AlloVir, Inc. - USD -Infinity%
Revance Therapeutics, Inc. 234.04 Million USD 99.934%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
Aura Biosciences, Inc. - USD -Infinity%
Immunic, Inc. - USD -Infinity%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 99.112%
Veracyte, Inc. 361.05 Million USD 99.957%
InMed Pharmaceuticals Inc. 4.59 Million USD 96.629%
FibroGen, Inc. 147.75 Million USD 99.895%
SeaStar Medical Holding Corporation - USD -Infinity%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.961%
Adial Pharmaceuticals, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD -4.868%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD 63.095%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.959%
Fortrea Holdings Inc. 3.1 Billion USD 99.995%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
XBiotech Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
Keros Therapeutics, Inc. 151 Thousand USD -2.649%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Lyra Therapeutics, Inc. 1.55 Million USD 90.051%
Foghorn Therapeutics Inc. 34.15 Million USD 99.546%
Agenus Inc. 156.31 Million USD 99.901%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 99.817%
Theravance Biopharma, Inc. 57.42 Million USD 99.73%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.964%
Metagenomi, Inc. Common Stock 44.75 Million USD 99.654%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.953%
Gain Therapeutics, Inc. 55.18 Thousand USD -180.899%
C4 Therapeutics, Inc. 20.75 Million USD 99.253%
Creative Medical Technology Holdings, Inc. 9000.00 USD -1622.222%
Chemomab Therapeutics Ltd. - USD -Infinity%
Lantern Pharma Inc. - USD -Infinity%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
Ainos, Inc. 122.11 Thousand USD -26.933%
Pluri Inc. 326 Thousand USD 52.454%
Prothena Corporation plc 91.37 Million USD 99.83%
Adaptimmune Therapeutics plc 60.28 Million USD 99.743%
Rallybio Corporation - USD -Infinity%
Kodiak Sciences Inc. - USD -Infinity%
Cue Biopharma, Inc. 5.49 Million USD 97.177%
MeiraGTx Holdings plc 14.01 Million USD 98.894%
Annexon, Inc. - USD -Infinity%
Assembly Biosciences, Inc. 7.16 Million USD 97.836%
Moderna, Inc. 6.84 Billion USD 99.998%
Cocrystal Pharma, Inc. - USD -Infinity%
Cidara Therapeutics, Inc. 63.9 Million USD 99.757%
Blueprint Medicines Corporation 249.38 Million USD 99.938%
Immix Biopharma, Inc. - USD -Infinity%
CalciMedica, Inc. - USD -Infinity%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Scholar Rock Holding Corporation - USD -Infinity%
Wave Life Sciences Ltd. 113.3 Million USD 99.863%
Sana Biotechnology, Inc. - USD -Infinity%
Elicio Therapeutics, Inc. - USD -Infinity%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 96.897%
Nutriband Inc. 2.08 Million USD 92.567%
Protara Therapeutics, Inc. - USD -Infinity%
Vor Biopharma Inc. - USD -Infinity%
Roivant Sciences Ltd. 124.79 Million USD 99.876%
Alkermes plc 1.66 Billion USD 99.991%
ProKidney Corp. - USD -Infinity%
Applied Therapeutics, Inc. 9.99 Million USD 98.449%
Arcellx, Inc. 110.31 Million USD 99.859%
BridgeBio Pharma, Inc. 9.3 Million USD 98.334%
Tango Therapeutics, Inc. 36.52 Million USD 99.576%
Galectin Therapeutics Inc. - USD -Infinity%
Atai Life Sciences N.V. 314 Thousand USD 50.637%
Renovaro Biosciences Inc. - USD -Infinity%
Aerovate Therapeutics, Inc. - USD -Infinity%
MediciNova, Inc. 1 Million USD 84.5%
Praxis Precision Medicines, Inc. 2.44 Million USD 93.666%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -808.292%
GeoVax Labs, Inc. - USD -Infinity%
Axsome Therapeutics, Inc. 270.6 Million USD 99.943%
Biomea Fusion, Inc. - USD -Infinity%
RenovoRx, Inc. - USD -Infinity%
Cullinan Oncology, Inc. - USD -Infinity%
Geron Corporation 237 Thousand USD 34.599%
NRx Pharmaceuticals, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 99.252%
Dyne Therapeutics, Inc. - USD -Infinity%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.943%
Royalty Pharma plc 2.35 Billion USD 99.993%
Ventyx Biosciences, Inc. - USD -Infinity%
Imunon, Inc. - USD -Infinity%
BioAtla, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD -63.158%
Larimar Therapeutics, Inc. - USD -Infinity%
Mersana Therapeutics, Inc. 36.85 Million USD 99.579%
Structure Therapeutics Inc. - USD -Infinity%
89bio, Inc. - USD -Infinity%
Kezar Life Sciences, Inc. 7 Million USD 97.786%
aTyr Pharma, Inc. 353 Thousand USD 56.091%
Aligos Therapeutics, Inc. 15.52 Million USD 99.002%
Viridian Therapeutics, Inc. 314 Thousand USD 50.637%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -1185.347%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.981%
Lexicon Pharmaceuticals, Inc. 1.2 Million USD 87.126%
Liquidia Corporation 17.48 Million USD 99.114%
Entera Bio Ltd. - USD -Infinity%
GH Research PLC - USD -Infinity%
Vericel Corporation 197.51 Million USD 99.922%
Arbutus Biopharma Corporation 18.14 Million USD 99.146%
Xencor, Inc. 168.33 Million USD 99.908%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD 38.874%
Pasithea Therapeutics Corp. - USD -Infinity%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Vaxcyte, Inc. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.92%
Lexaria Bioscience Corp. 226.2 Thousand USD 31.479%
Portage Biotech Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -808.292%
Olema Pharmaceuticals, Inc. - USD -Infinity%
OncoCyte Corporation 1.5 Million USD 89.687%
Qualigen Therapeutics, Inc. 5.2 Million USD 97.022%
Processa Pharmaceuticals, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
Tempest Therapeutics, Inc. - USD -Infinity%
Sol-Gel Technologies Ltd. 1.55 Million USD 90.026%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 99.8%
CollPlant Biotechnologies Ltd. 10.95 Million USD 98.586%
Moleculin Biotech, Inc. - USD -Infinity%
United Therapeutics Corporation 2.32 Billion USD 99.993%
HilleVax, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD -114.973%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.937%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Apogee Therapeutics, Inc. - USD -Infinity%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
Pyxis Oncology, Inc. - USD -Infinity%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. - USD -Infinity%
Windtree Therapeutics, Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 98.454%
Carmell Therapeutics Corporation - USD -Infinity%
Achieve Life Sciences, Inc. - USD -Infinity%
BeiGene, Ltd. 2.45 Billion USD 99.994%
Protagonist Therapeutics, Inc. 60 Million USD 99.742%
Erasca, Inc. - USD -Infinity%
Protagenic Therapeutics, Inc. - USD -Infinity%
Protagenic Therapeutics, Inc. - USD -Infinity%
Vincerx Pharma, Inc. - USD -Infinity%
Fresh Tracks Therapeutics, Inc. 8 Million USD 98.064%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Celldex Therapeutics, Inc. 6.88 Million USD 97.748%
Cogent Biosciences, Inc. - USD -Infinity%
Adicet Bio, Inc. - USD -Infinity%
Amicus Therapeutics, Inc. 399.35 Million USD 99.961%
Aditxt, Inc. 645.17 Thousand USD 75.976%
Adagene Inc. 18.11 Million USD 99.144%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 85.675%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 250 Million USD 99.938%
Compugen Ltd. 33.45 Million USD 99.537%
Generation Bio Co. 5.9 Million USD 97.375%
Astria Therapeutics, Inc. - USD -Infinity%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Invivyd, Inc. - USD -Infinity%
Relay Therapeutics, Inc. 25.54 Million USD 99.393%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Spero Therapeutics, Inc. 96.73 Million USD 99.84%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 99.846%
Instil Bio, Inc. - USD -Infinity%
Capricor Therapeutics, Inc. 25.17 Million USD 99.384%
Elevai Labs, Inc. Common Stock 1.71 Million USD 90.949%
GeoVax Labs, Inc. - USD -Infinity%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Relmada Therapeutics, Inc. - USD -Infinity%
ALX Oncology Holdings Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 99.82%
Evaxion Biotech A/S 73.11 Thousand USD -112.004%
Ocular Therapeutix, Inc. 58.44 Million USD 99.735%
Verve Therapeutics, Inc. 11.75 Million USD 98.682%
Tyra Biosciences, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
Bolt Biotherapeutics, Inc. 7.87 Million USD 98.032%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
ImmunityBio, Inc. 622 Thousand USD 75.08%
Korro Bio, Inc. - USD -Infinity%
Kineta, Inc. 5.44 Million USD 97.152%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 99.779%
Celularity Inc. 22.77 Million USD 99.319%
Aileron Therapeutics, Inc. - USD -Infinity%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 96.138%
Virax Biolabs Group Limited 156.41 Thousand USD 0.907%
Cibus, Inc. 1.81 Million USD 91.469%
IN8bio, Inc. - USD -Infinity%
Adverum Biotechnologies, Inc. 3.6 Million USD 95.694%
Avalo Therapeutics, Inc. 1.92 Million USD 91.944%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.98%
Eyenovia, Inc. 3787.00 USD -3992.95%
Puma Biotechnology, Inc. 235.63 Million USD 99.934%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Elevation Oncology, Inc. - USD -Infinity%
Xilio Therapeutics, Inc. - USD -Infinity%
Cardiff Oncology, Inc. 488 Thousand USD 68.238%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 99.804%
Regulus Therapeutics Inc. - USD -Infinity%
Moolec Science SA 905.04 Thousand USD 82.874%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
LAVA Therapeutics N.V. 6.76 Million USD 97.71%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Compass Therapeutics, Inc. - USD -Infinity%
Greenwich LifeSciences, Inc. - USD -Infinity%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD 78.879%
Humacyte, Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
Avenue Therapeutics, Inc. - USD -Infinity%
Genelux Corporation 170 Thousand USD 8.824%
Trevi Therapeutics, Inc. - USD -Infinity%
Notable Labs, Ltd. 310 Thousand USD 50.0%
Immunovant, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 85.675%
DiaMedica Therapeutics Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 91.676%
Acasti Pharma Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Soleno Therapeutics, Inc. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Nuvectis Pharma, Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Belite Bio, Inc - USD -Infinity%
XOMA Corporation 4.75 Million USD 96.742%
ARS Pharmaceuticals, Inc. 30 Thousand USD -416.667%
Bionomics Limited - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
uniQure N.V. 15.84 Million USD 99.022%
Estrella Immunopharma, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 99.76%
Forte Biosciences, Inc. - USD -Infinity%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
Conduit Pharmaceuticals Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Altimmune, Inc. 426 Thousand USD 63.615%
LENZ Therapeutics, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD 57.866%
Zevra Therapeutics, Inc. 27.46 Million USD 99.436%
Benitec Biopharma Inc. 216 Thousand USD 28.241%
Spyre Therapeutics, Inc. 886 Thousand USD 82.506%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Zura Bio Limited - USD -Infinity%
PolyPid Ltd. - USD -Infinity%
NKGen Biotech, Inc. Warrants - USD -Infinity%
argenx SE 1.22 Billion USD 99.987%
Immunome, Inc. 14.01 Million USD 98.894%
Verona Pharma plc - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Shattuck Labs, Inc. 1.65 Million USD 90.646%
CervoMed Inc. 7.14 Million USD 97.831%
Plus Therapeutics, Inc. 4.91 Million USD 96.845%
Dianthus Therapeutics, Inc. 2.82 Million USD 94.515%
Moolec Science SA 905.04 Thousand USD 82.874%
Enveric Biosciences, Inc. - USD -Infinity%
Design Therapeutics, Inc. - USD -Infinity%
Leap Therapeutics, Inc. - USD -Infinity%
Seelos Therapeutics, Inc. 2.2 Million USD 92.964%
Achilles Therapeutics plc - USD -Infinity%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
CG Oncology, Inc. Common stock 204 Thousand USD 24.02%
Fractyl Health, Inc. Common Stock 120 Thousand USD -29.167%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Tourmaline Bio, Inc. - USD -Infinity%
Beam Therapeutics Inc. 377.7 Million USD 99.959%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.917%
AEON Biopharma, Inc. - USD -Infinity%
Aadi Bioscience, Inc. 24.35 Million USD 99.364%
Enliven Therapeutics, Inc. - USD -Infinity%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
NeurAxis, Inc. 2.46 Million USD 93.699%
Iovance Biotherapeutics, Inc. 1.18 Million USD 86.964%
Lumos Pharma, Inc. 2.05 Million USD 92.443%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 99.619%
Palisade Bio, Inc. 250 Thousand USD 38.0%
Nutriband Inc. 2.08 Million USD 92.567%
Taysha Gene Therapies, Inc. 15.45 Million USD 98.997%
Neurogene Inc. - USD -Infinity%
Kintara Therapeutics, Inc. - USD -Infinity%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Athira Pharma, Inc. - USD -Infinity%
HCW Biologics Inc. 2.84 Million USD 94.546%
XOMA Corporation 4.75 Million USD 96.742%
Nektar Therapeutics 90.12 Million USD 99.828%
Arvinas, Inc. 78.5 Million USD 99.803%
Tevogen Bio Holdings Inc. - USD -Infinity%
Merus N.V. 43.94 Million USD 99.647%
Omega Therapeutics, Inc. 3.09 Million USD 94.99%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD 76.3%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD 91.148%
Synlogic, Inc. 3.37 Million USD 95.402%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD 57.866%
Werewolf Therapeutics, Inc. 19.94 Million USD 99.223%
Krystal Biotech, Inc. 50.69 Million USD 99.694%
Karyopharm Therapeutics Inc. 146.03 Million USD 99.894%
SpringWorks Therapeutics, Inc. 5.44 Million USD 97.154%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD 65.526%
MannKind Corporation 198.96 Million USD 99.922%
Ikena Oncology, Inc. 9.16 Million USD 98.308%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 99.863%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.946%
Mural Oncology plc - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 99.691%
REGENXBIO Inc. 90.24 Million USD 99.828%
Ensysce Biosciences, Inc. 2.23 Million USD 93.051%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 97.899%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD 79.47%
Longeveron Inc. 709 Thousand USD 78.138%
Repare Therapeutics Inc. 51.13 Million USD 99.697%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.988%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 98.661%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD 26.19%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 99.998%
Denali Therapeutics Inc. 330.53 Million USD 99.953%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 99.049%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 94.266%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD -1.686%
Carisma Therapeutics, Inc. 14.91 Million USD 98.961%
Unicycive Therapeutics, Inc. 675 Thousand USD 77.037%
OmniAb, Inc. 34.16 Million USD 99.546%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 99.271%
Lipocine Inc. -2.85 Million USD 105.437%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 93.077%
G1 Therapeutics, Inc. 82.51 Million USD 99.812%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 99.821%
Ocugen, Inc. 6.03 Million USD 97.432%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Q32 Bio Inc. 1.15 Million USD 86.592%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 99.57%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 97.418%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Dominari Holdings Inc. 2.03 Million USD 92.398%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.987%
Agios Pharmaceuticals, Inc. 26.82 Million USD 99.422%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.973%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 98.769%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD 67.505%
Iterum Therapeutics plc - USD -Infinity%